5--3-f Ӣ 5-acetyl-1,2-oxazole-3-carboxylic acid ܶ 1.416g/cm3 c(din) 402.6?C at 760mmHg ʽ C6H5NO4 155.10800 Wc(din) 197.3?C |(zh) 155.02200
؛̖(ho) | Ҏ(gu) | (sh) | r(ji) |
---|---|---|---|
Q-0107263 | 100mg |
1
|
ԃr(ji) |
Q-0107263 | 250mg |
1
|
ԃr(ji) |
Q-0107263 | 500mg |
1
|
ԃr(ji) |
Q-0107263 | 1g |
1
|
ԃr(ji) |
Q-0107263 | 5g |
1
|
ԃr(ji) |

5--3-f
Ӣ 5-acetyl-1,2-oxazole-3-carboxylic acid
ܶ 1.416g/cm3
c(din) 402.6ºC at 760mmHg
ʽ C6H5NO4
155.10800
Wc(din) 197.3ºC
|(zh) 155.02200
PSA 80.40000
LogP 0.57540
0mmHg at 25°C
1.526
P(gun)a(chn)Ʒ
(S)-2--3-((S)-2--3-)}} CAS:2628280-48-6
(R)-ʰ嶡}} CAS:256478-95-2
3,4--2-(()) CAS:2136287-65-3
N-(5,6-һ-2,3--1H--2-)-2,2,2- CAS:601487-87-0
N-̪-DL-Ȱ CAS:3343-28-0
4--3--2- CAS:170621-86-0
ʲ@ CAS:53956-04-1
B(ti)w/ĩ/Һ
a(chn)أ
(ch)r(sh)g1
棺
;
SңpgӹٷƼ˾

(sh)Ϣ | |
---|---|
^B(ti) | wĩ |
|(zh)ָ(bio) | 95%+ |
ܽl | ЙC(j)܄/ˮ |
CAS̖(ho) | N/A |
N/A | |
(ch)l | -20ܹⱣ |
(ch)r(sh)g | 1 |
\(yn)ݔl | Ҝ2 |
a(chn)Sң | pgӹٷƼ˾ |
-
pgӹٷƼ˾ṩ Danoprevir;ITMN-191; R7227; RO5190591; RG7227CAS850876-88-9 ^N/A N/A Hʹ
-
pgӹٷƼ˾ṩ DalfopristinCAS112362-50-2 ^N/A N/A Hʹã
-
2-(5--3-) Ӣ ethyl 2-(5-bromopyridin-3-yl)acetate CAS̖(ho) 847375-33-1 244.08500 ܶ N/A
-
N-(1-(-1-)һ)-3-(3-()) Ӣ N-(1-naphthalen-1-ylethyl)-3-[3-(trifluoromethyl)phenyl]propanamide ʽ C22H20F3NO 371.39600 |(zh) 371.15000 PSA 29.10000 LogP 6.05950